Rubella Diagnostic Testing Market size was valued at US$ 4.69 Bn. in 2021 and the total revenue is expected to grow at 4.5% through 2021 to 2029, reaching nearly US$ 6.67 Bn. by 2029.Rubella Diagnostic Testing Market Overview:
Rubella diagnostic testing is a procedure carried out for the detection of antibodies that are developed by the immune system to destroy the rubella viruses. The virus responsible for the rubella infection is positive-stranded RNA Virus as a rubivirus in the matanviridae family. Being a contagious virus, it spreads from one person to another by coughing or sneezing by an infected person.To know about the Research Methodology :- Request Free Sample Report
Rubella Diagnostic Testing Market Dynamics:
Increasing no. of rubella diagnostic testing with government initiatives to control the infection rate and advancement in point-of-care diagnosis is estimated to fuel the growth of the market in the forecast period. As per WHO in December 2021, 168 out of 195 countries had introduced rubella vaccines and the global coverage was estimated at 69%. Further, the cases were reduced from 670893 reported casts from 102 countries in the year 2000 to 14621 reported cases in 151 countries in 2021. Moreover, CSR rates are higher in WHO African and South-East Asian region due to lower vaccination coverages. This factor is likely to boost the rubella diagnostic testing in Africa as compared to other regions globally. Moreover, government initiatives towards the end-to-end vaccination by the government by organizing healthcare programs for free of cost vaccination are likely to boost the growth of the market in the forecast period. Further, new products launch by the market players is playing a vital role in the market. For instance, Abbott Company launched a test kit for rubella virus named as Abbott Rubella-PLUS Test. As a result, this test offers simple and accurate with quick result optimization detection of rubella antibodies.Rubella Diagnostic Testing Market Segment Analysis:
The Enzyme Immunoassay segment is considered to supplement the growth of the Global Rubella Diagnostic Testing Market The enzyme immunoassay segment is dominating the Rubella diagnostic testing market with the largest market share of USD 21400 million in 2021 with a CAGR of 6.7% during the forecast period. Enzyme Immunoassay is the standard test for the detection of rubella-specific immunoglobulins M(IgM) in the serum for rapid laboratory diagnosis of rubella. IgM is the most preferred test for the rubella virus with the help of commercial enzyme immunoassay (EIA). The companies manufacturing the Enzyme Immunoassay system are focusing on product development and mergers and acquisitions to sustain themselves in the market. The major companies are Biohit Oyj, DIA LAB Services Srl, Dynex Technologies, Inc., Fujirebio, Inova Diagnostics, Meril Life Sciences, Tosoh, bioMérieux. Due to these factors, companies are gaining more attention and wider adoption of the diagnostic system. Ans this factor is likely to motivate the market. In Nov 2021, bioMérieux acquired the majority of the share stake in Suzhou Hybiome Biomedical Engineering Co. Ltd. As a result, to strengthen the company’s presence in China Market. The Hospital segment is dominating the application segment of the Global Rubella Diagnostic Testing Market: The hospital segment is dominating the application segment of the global rubella diagnostic testing market with a market share of 34% in 2021 and is estimated to grow at a high pace during the forecast period. The growth of the segment is attributed to the rising no. of hospitals and the implementation of technologies for rapid results. Moreover, healthcare industries are growing at a rapid pace in the market due to government funding and policies. The rising prevalence of infectious diseases is likely to motivate the growth of the market in the coming future. As the growth of the infectious disease is hitting the market and values for 29.3% in 2021. Hence, these factors are likely to motivate the growth of rubella diagnostics in the forecast period.Rubella Diagnostic Testing Market Regional Insights:
Asia Pacific is gaining a significant market share with the highest CAGR of 12.3% during the forecast period. Moreover, rising population and improving healthcare facilities with easy access are likely to boost the growth of the market. Further, increasing demand for cut healthcare expenses is likely to boost the growth of the market. The dominating countries of Asia Pacific are India, China, and Japan due to the presence of prominent market players in the region. Further, Asia Pacific has registered the fastest growth rate for the rubella diagnostics testing market is likely to grow at the same pace in the future. Besides, lack of awareness in an underdeveloped country, and government initiatives are likely to retain the market growth. North America is likely to gain significant market share in the Rubella Diagnostic Testing market with 8.7% of the market share in 2021. In addition, mergers, acquisitions, and the launching of new products are likely to boost the growth of the market during the forecast period. The objective of the report is to present a comprehensive analysis of the Global Rubella Diagnostic Testing Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Global Rubella Diagnostic Testing Market dynamics, structure by analyzing the market segments and project the Global Rubella Diagnostic Testing Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Global Rubella Diagnostic Testing Market make the report investor’s guide.Rubella Diagnostic Testing Market Scope: Inquire before buying
Rubella Diagnostic Testing Market Base Year 2021 Forecast Period 2022-2029 Historical Data CAGR Market Size in 2021 Market Size in 2029 2017 to 2021 4.5% US$ 4.69 Bn US$ 6.67 Bn Segments Covered by Testing Technique • Latex Agglutination • Enzyme Immunoassay (EIA) • Radioimmunoassay (RIA) • Fluorescent Immunoassay (FIA) • Other Testing Techniques by Application • Hospitals • Laboratories • Other Applications Regions Covered North America • United States • Canada • Mexico Europe • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest of Europe Asia Pacific • China • S Korea • Japan • India • Australia • Indonesia • Malaysia • Vietnam • Taiwan • Bangladesh • Pakistan • Rest of APAC Middle East and Africa • South Africa • GCC • Egypt • Nigeria • Rest of ME&A South America • Brazil • Argentina • Rest of South America Rubella Diagnostic Testing Market Key Player
• Abbott • Bio Rad Laboratories Inc. • bioMérieux SA • Siemens Healthcare GmbH • Thermo Fisher Scientific Inc. • Biohit Oyj • DIA LAB Services Srl • Dynex Technologies, Inc. • Fujirebio • Inova Diagnostics • Meril Life Sciences • TosohFAQs:
1. What is the global Rubella Diagnostic Testing market share in 2021? Ans: Approximately, 4.69 Billion USD. 2. What is the global Rubella Diagnostic Testing market growth? Ans: The global Rubella Diagnostic Testing market is anticipated to grow with a CAGR of 4.6% in the forecast period and is likely to reach USD 6.67 Billion by the end of 2029. 3. Which Application segment is expected to dominate the global Rubella Diagnostic Testing market during the forecast period? Ans: The Hospital segment dominated the Rubella Diagnostic Testing market with a Market share of 34 % in 2021. 4. Which region is expected to dominate the global Rubella Diagnostic Testing market during the forecast period? Ans: Asia pacific dominated the Rubella Diagnostic Testing market with a share of over 12.3% in 2021 owing to rising various drug innovations and diagnostic treatments. 5. Who are the key players in the global Rubella Diagnostic Testing market? Ans: Key players of the market include Abbott, Bio Rad Laboratories Inc., bioMérieux SA, Siemens Healthcare GmbH, Thermo Fisher Scientific In
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Rubella Diagnostic Testing Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2021 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Rubella Diagnostic Testing Market 3.4. Geographical Snapshot of the Rubella Diagnostic Testing Market, By Manufacturer share 4. Global Rubella Diagnostic Testing Market Overview, 2021-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Grades 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Rubella Diagnostic Testing Market 5. Supply Side and Demand Side Indicators 6. Global Rubella Diagnostic Testing Market Analysis and Forecast, 2021-2029 6.1. Global Rubella Diagnostic Testing Market Size & Y-o-Y Growth Analysis. 7. Global Rubella Diagnostic Testing Market Analysis and Forecasts, 2021-2029 7.1. Market Size (Value) Estimates & Forecast By Testing Technique, 2021-2029 7.1.1. Latex Agglutination 7.1.2. Enzyme Immunoassay (EIA) 7.1.3. Radioimmunoassay (RIA) 7.1.4. Fluorescent Immunoassay (FIA) 7.1.5. Other Testing Techniques 7.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 7.2.1. Hospitals 7.2.2. Laboratories 7.2.3. Other Applications 8. Global Rubella Diagnostic Testing Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2021-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Rubella Diagnostic Testing Market Analysis and Forecasts, 2021-2029 9.1. Market Size (Value) Estimates & Forecast By Testing Technique, 2021-2029 9.1.1. Latex Agglutination 9.1.2. Enzyme Immunoassay (EIA) 9.1.3. Radioimmunoassay (RIA) 9.1.4. Fluorescent Immunoassay (FIA) 9.1.5. Other Testing Techniques 9.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 9.2.1. Hospitals 9.2.2. Laboratories 9.2.3. Other Applications 10. North America Rubella Diagnostic Testing Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Rubella Diagnostic Testing Market Analysis and Forecasts, 2021-2029 11.1. Market Size (Value) Estimates & Forecast By Testing Techniques, 2021-2029 11.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 12. Canada Rubella Diagnostic Testing Market Analysis and Forecasts, 2021-2029 12.1. Market Size (Value) Estimates & Forecast By Testing Techniques, 2021-2029 12.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 13. Mexico Rubella Diagnostic Testing Market Analysis and Forecasts, 2021-2029 13.1. Market Size (Value) Estimates & Forecast By Testing Techniques, 2021-2029 13.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 14. Europe Rubella Diagnostic Testing Market Analysis and Forecasts, 2021-2029 14.1. Market Size (Value) Estimates & Forecast By Testing Techniques, 2021-2029 14.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 15. Europe Rubella Diagnostic Testing Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K Rubella Diagnostic Testing Market Analysis and Forecasts, 2021-2029 16.1. Market Size (Value) Estimates & Forecast By Testing Techniques, 2021-2029 16.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 17. France Rubella Diagnostic Testing Market Analysis and Forecasts, 2021-2029 17.1. Market Size (Value) Estimates & Forecast By Testing Techniques, 2021-2029 17.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 18. Germany Rubella Diagnostic Testing Market Analysis and Forecasts, 2021-2029 18.1. Market Size (Value) Estimates & Forecast By Testing Techniques, 2021-2029 18.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 19. Italy Rubella Diagnostic Testing Market Analysis and Forecasts, 2021-2029 19.1. Market Size (Value) Estimates & Forecast By Testing Techniques, 2021-2029 19.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 20. Spain Rubella Diagnostic Testing Market Analysis and Forecasts, 2021-2029 20.1. Market Size (Value) Estimates & Forecast By Testing Techniques, 2021-2029 20.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 21. Sweden Rubella Diagnostic Testing Market Analysis and Forecasts, 2021-2029 21.1. Market Size (Value) Estimates & Forecast By Testing Techniques, 2021-2029 21.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 22. CIS Countries Rubella Diagnostic Testing Market Analysis and Forecasts, 2021-2029 22.1. Market Size (Value) Estimates & Forecast By Testing Techniques, 2021-2029 22.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 23. Rest of Europe Rubella Diagnostic Testing Market Analysis and Forecasts, 2021-2029 23.1. Market Size (Value) Estimates & Forecast By Testing Techniques, 2021-2029 23.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 24. Asia Pacific Rubella Diagnostic Testing Market Analysis and Forecasts, 2021-2029 24.1. Market Size (Value) Estimates & Forecast By Testing Techniques, 2021-2029 24.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 25. Asia Pacific Rubella Diagnostic Testing Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Rubella Diagnostic Testing Market Analysis and Forecasts, 2021-2029 26.1. Market Size (Value) Estimates & Forecast By Testing Techniques, 2021-2029 26.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 27. India Rubella Diagnostic Testing Market Analysis and Forecasts, 2021-2029 27.1. Market Size (Value) Estimates & Forecast By Testing Techniques, 2021-2029 27.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 28. Japan Rubella Diagnostic Testing Market Analysis and Forecasts, 2021-2029 28.1. Market Size (Value) Estimates & Forecast By Testing Techniques, 2021-2029 28.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 29. South Korea Rubella Diagnostic Testing Market Analysis and Forecasts, 2021-2029 29.1. Market Size (Value) Estimates & Forecast By Testing Techniques, 2021-2029 29.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 30. Australia Rubella Diagnostic Testing Market Analysis and Forecasts, 2021-2029 30.1. Market Size (Value) Estimates & Forecast By Testing Techniques, 2021-2029 30.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 31. ASEAN Rubella Diagnostic Testing Market Analysis and Forecasts, 2021-2029 31.1. Market Size (Value) Estimates & Forecast By Testing Techniques, 2021-2029 31.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 32. Rest of Asia Pacific Rubella Diagnostic Testing Market Analysis and Forecasts, 2021-2029 32.1. Market Size (Value) Estimates & Forecast By Testing Techniques, 2021-2029 32.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 33. Middle East Africa Rubella Diagnostic Testing Market Analysis and Forecasts, 2021-2029 33.1. Market Size (Value) Estimates & Forecast By Testing Techniques, 2021-2029 33.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 34. Middle East Africa Rubella Diagnostic Testing Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2021-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Rubella Diagnostic Testing Market Analysis and Forecasts, 2021-2029 35.1. Market Size (Value) Estimates & Forecast By Testing Techniques, 2021-2029 35.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 36. GCC Countries Rubella Diagnostic Testing Market Analysis and Forecasts, 2021-2029 36.1. Market Size (Value) Estimates & Forecast By Testing Techniques, 2021-2029 36.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 37. Egypt Textile Reinforced Concrete e Market Analysis and Forecasts, 2021-2029 37.1. Market Size (Value) Estimates & Forecast By Testing Techniques, 2021-2029 37.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 38. Nigeria Rubella Diagnostic Testing Market Analysis and Forecasts, 2021-2029 38.1. Market Size (Value) Estimates & Forecast By Testing Techniques, 2021-2029 38.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 39. Rest of ME&A Rubella Diagnostic Testing Market Analysis and Forecasts, 2021-2029 39.1. Market Size (Value) Estimates & Forecast By Testing Techniques, 2021-2029 39.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 40. South America Rubella Diagnostic Testing Market Analysis and Forecasts, 2021-2029 40.1. Market Size (Value) Estimates & Forecast By Testing Techniques, 2021-2029 40.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 41. South America Rubella Diagnostic Testing Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2021-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Rubella Diagnostic Testing Market Analysis and Forecasts, 2021-2029 42.1. Market Size (Value) Estimates & Forecast By Testing Techniques, 2021-2029 42.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 43. Argentina Rubella Diagnostic Testing Market Analysis and Forecasts, 2021-2029 43.1. Market Size (Value) Estimates & Forecast By Testing Techniques, 2021-2029 43.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 44. Rest of South America Rubella Diagnostic Testing Market Analysis and Forecasts, 2021-2029 44.1. Market Size (Value) Estimates & Forecast By Testing Techniques, 2021-2029 44.2. Market Size (Value) Estimates & Forecast By Application, 2021-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Rubella Diagnostic Testing Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Fiber Grades and R&D Investment 45.2.2. New Grade Launches and Grade Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Natus Medical, Inc 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Grade Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Development 45.3.2. Abbott 45.3.3. Bio Rad Laboratories Inc. 45.3.4. bioMérieux SA 45.3.5. Siemens Healthcare GmbH 45.3.6. Thermo Fisher Scientific Inc. 45.3.7. Biohit Oyj 45.3.8. DIA LAB Services Srl 45.3.9. Dynex Technologies, Inc. 45.3.10. Fujirebio 45.3.11. Inova Diagnostics 45.3.12. Meril Life Sciences 45.3.13. Tosoh 46. Primary Key Insights